HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

trans-4-((1R)-2-((5S)-6-Fluoro-5H-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexanol

HCID 70914230
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1402837-78-8
Standard SMILES
OC1CCC([C@H](O)C[C@H]2c3c(F)cccc3-c3cncn32)CC1
InChIKey
YGACXVRLDHEXKY-YYJRJVKZNA-N
Molecular formula
C18H21FN2O2
Average molar mass
316.4 g/mol
Monoisotopic mass
316.15870608

Overview

Navoximod is under investigation in clinical trial NCT02048709 (Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors).

Names & identifiers

Preferred name
trans-4-((1R)-2-((5S)-6-Fluoro-5H-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexanol
IUPAC
4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol
English name
IDO-IN-7
Molecular formula
C18H21FN2O2
Molecular weight
316.38

Names & synonyms

Trans-4-((1R)-2-((5S)-6-Fluoro-5H-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexanolRefChem:933272Navoximod1402837-78-8IDO-IN-7NLG-919Navoximod [USAN]GDC-0919UNII-926SHL95NC926SHL95NCNLG-919 NavoximodNAVOXIMOD [INN]
Show more names
Navoximod (NLG919)IDO-IN-7(Navoximod)Reaxys ID: 22999399Navoximod (GDC-0919Navoximod free baseNavoximod, 10 mM in DMSONavoximod (Synonyms: GDC-0919GDC-0917CUDC427CUDC 427GDC0917GDC 0917
RO7077339-001trans-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-olRG6078RG-6078US10233190, Example 1484RO7077339RO-7077339F85292

Database identifiers

CAS
1402837-78-8

Properties

Computed structural propertiesFilling in

XLogP
2.1
Topological polar surface area
58.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
23
Formal charge
0
Complexity
416

Physicochemical properties

Boiling point
555.4 · 555.4±35.0 °C(Predicted)
Density
1.42 · 1.42±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
100 · DMSO:100.0(Max Conc. mg/mL);316.09(Max Conc. mM)
pka
14.66 · 14.66±0.20(Predicted)
form
Solid
color
White to light yellow
InChI
InChI=1/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11-,12-,15-,17+/s3
InChIKey
YGACXVRLDHEXKY-YYJRJVKZNA-N
SMILES
C([C@@H]1N2C=NC=C2C2=CC=CC(F)=C12)[C@H]([C@]1([H])CC[C@@H](O)CC1)O |&1:1,14,15,19,r|
FDA UNII
926 SHL95NC · 926SHL95NC

Chemistry & industry

Applications

UsesNavoximod (GDC-0919; NLG-919) is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
PubChem CID
70914230
ChEMBL
CHEMBL4530496
UNII
926SHL95NC
Nikkaji
J3.754.916I